218 related articles for article (PubMed ID: 3548633)
21. [High-dose busulfan, VP-16 and ACNU therapy with stem cell transplantation for the treatment of children with acute leukemia].
Ikuta K; Fujioka K; Sumita H; Takahashi H; Sekiguchi H; Kai S; Kajigaya Y; Funabiki T; Sakai H; Matsuyama S
Rinsho Ketsueki; 1993 May; 34(5):636-42. PubMed ID: 8100284
[TBL] [Abstract][Full Text] [Related]
22. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women.
Singhal S; Powles R; Treleaven J; Horton C; Swansbury GJ; Mehta J
Bone Marrow Transplant; 1996 Dec; 18(6):1049-55. PubMed ID: 8971372
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of allogeneic bone marrow transplantation in patients with acute leukemia in complete remission and in patients with chronic myeloid leukemia during the chronic phase].
Liubimova LS; Savchenko VG; Mendeleeva LP; Kliasova GA; Gribanova EO; Demidova IA; Gal'tseva IV; Kuz'mina LA; Momotiuk KS; Kuliev RG
Ter Arkh; 1999; 71(7):27-32. PubMed ID: 10481864
[TBL] [Abstract][Full Text] [Related]
24. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
25. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
26. Status of allogeneic bone marrow transplantation in childhood in the GDR.
Zintl F; Hermann J; Fuchs D; Prager J; Müller A; Reiners B; Burger E; Goetz I; Kob D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):389-96. PubMed ID: 2480279
[TBL] [Abstract][Full Text] [Related]
27. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
29. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
[TBL] [Abstract][Full Text] [Related]
30. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
Santos GW; Tutschka PJ; Brookmeyer R; Saral R; Beschorner WE; Bias WB; Braine HG; Burns WH; Elfenbein GJ; Kaizer H
N Engl J Med; 1983 Dec; 309(22):1347-53. PubMed ID: 6355849
[TBL] [Abstract][Full Text] [Related]
31. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
32. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
33. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
[TBL] [Abstract][Full Text] [Related]
34. Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
Schiffman K; Clift R; Appelbaum FR; Sanders J; Bensinger W; Petersen FB; Rowley S; Hill R; Martin P; Storb R
Bone Marrow Transplant; 1993 Mar; 11(3):227-32. PubMed ID: 8467288
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
36. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
38. Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission.
Michel G; Maraninchi D; Demeocq F; Perrimond H; Blaise D; Gaspard MH; Stoppa AM; Gastaut JA; Lepeu G; Novakovitch G
Bone Marrow Transplant; 1988 Mar; 3(2):105-11. PubMed ID: 3048474
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide.
Angelucci E; Polchi P; Lucarelli G; Galimberti M; Baronciani D; Giardini C; Durazzi SM; Moretti L; Donati M
Haematologica; 1989; 74(5):455-61. PubMed ID: 2511115
[TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow transplantation for acute myeloid leukaemia in children using total body irradiation and melphalan as conditioning regimen.
Bonetti F; Montagna D; Porta F; Lanfranchi A; Zecca M; Comoli P; Personeni A; Gritti G; Maccario R; DeStefano P
Leukemia; 1995 Apr; 9(4):570-5. PubMed ID: 7723386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]